Seegene’s Q1 sales increased by nearly 30%, with operating profit and net profit turning positive. Diagnostic reagent sales grew by 30.4%, non-COVID diagnostic reagent sales by 37.5%, and extraction reagent sales by 24.7%. Europe accounted for the highest proportion of sales at 64%, followed by Asia at 15%, Korea at 9%, Latin America at 7%, and North America at 4%.
Original Article: Read More
Auto-posted at: 2025-05-09 21:01:21